| 1. Book Review: New Theory and Technique for Nerve-Sparing Radical Hysterectomy. |
Page:260—260 |
| 2. A favorable maternal and neonatal outcome following chemotherapy with etoposide, bleomycin, and cisplatin for management of grade 3 immature teratoma of the ovary. |
Page:257—259 |
| 3. Pregnancy following vulvar squamous cell carcinoma: a report of two cases. |
Page:254—256 |
| 4. A case of advanced gynecologic pelvic tumors showing the diagnostic utility of HPV analysis. |
Page:251—253 |
| 5. Chemotherapy and patient co-morbidity in ventral site hernia development. |
Page:246—250 |
| 6. Epstein-Barr virus-transformation of B-cell lines in ovarian cancer patients: feasibility of genomic storage for unlimited use. |
Page:243—245 |
| 7. A hospital-based case-control study of identifying ovarian cancer using symptom index. |
Page:238—242 |
| 8. Atlas of procedures in Laparoscopic Hysterectomy. |
Page:134—134 |
| 9. In reply. |
Page:133—133 |
| 10. Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy: To the editor. |
Page:132—132 |
| 11. Metastatic carcinoma of cervix mimicking psoas abscess on imaging: a case report. |
Page:129—131 |
| 12. A case of mucinous adenocarcinoma arising from retroperitoneal teratoma treated with chemoradiation. |
Page:126—128 |
| 13. A case of multiple metastatic low-grade endometrial stromal sarcoma arising from an ovarian endometriotic lesion. |
Page:122—125 |
| 14. Expression and mutational analysis of TGF-beta/Smads signaling in human cervical cancers. |
Page:117—121 |
| 15. TRAIL-induced cell death and caspase-8 activation are inhibited by cisplatin but not carboplatin. |
Page:113—116 |
| 16. Surgical practice patterns in endometrial cancer: results of the Korean Gynecologic Oncology Group survey. |
Page:107—112 |
| 17. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. |
Page:101—106 |
| 18. Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer. |
Page:96—100 |
| 19. Factors associated with HPV persistence after conization in patients with negative margins. |
Page:91—95 |
| 20. Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia. |
Page:86—90 |
| 21. ASCO's 45th Annual Meeting, May 29-June 2, 2009. |
Page:84—85 |
| 22. Epidemiologic report of gynecologic cancer in Thailand. |
Page:81—83 |
| 23. Current status of gynecological cancer care in India. |
Page:77—80 |
| 24. Current status of gynecological cancer in China. |
Page:72—76 |
| 25. Current status of gynecologic cancer in Japan. |
Page:67—71 |
| 26. Asian Society of Gynecologic Oncology (ASGO): a central platform against gynecologic cancers in Asia. |
Page:65—66 |
| 27. The utility of the human papillomavirus DNA load for the diagnosis and prediction of persistent vaginal intraepithelial neoplasia. |
Page:232—237 |
| 28. Treatment outcomes and prognostic factors in uterine cervical cancer patients treated with postoperative extended field radiation therapy. |
Page:227—231 |
| 29. Weekly cisplatin or gemcitabine concomitant with radiation in the management of locally advanced carcinoma cervix: results from an observational study. |
Page:221—226 |
| 30. Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma. |
Page:215—220 |
| 31. KGOG's & KSGOC's Symposium, Nov. 12-13, 2009. |
Page:213—214 |
| 32. ASGO's First Biennial Meeting, Nov. 22, 2009. |
Page:210—212 |
| 33. Major clinical research advances in gynecologic cancer 2009. |
Page:203—209 |
| 34. Time for global efforts with clinical trials for advanced cervical cancer patients. |
Page:201—202 |
| 35. Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer. |
Page:22—27 |
| 36. Differing prognosis of cervical cancer patients with high risk of treatment failure after radical hysterectomy warrants trial treatment modification. |
Page:17—21 |
| 37. Epidemiology, prevention and treatment of cervical cancer in the Philippines. |
Page:11—16 |
| 38. Gynecological cancer in Indonesia. |
Page:8—10 |
| 39. Current status of cervical cancer and HPV infection in Korea. |
Page:1—7 |
| 40. Vaginal evisceration after radical hysterectomy and adjuvant radiation. |
Page:63—64 |
| 41. A case of clear cell carcinoma arising from the endometriosis of the paraovarian cyst. |
Page:60—62 |
| 42. Postoperative acute renal failure in patients with gynecologic malignancies: analysis of 10 cases and review of the literature. |
Page:55—59 |
| 43. Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines. |
Page:48—54 |
| 44. Fertility preservation in patients with early epithelial ovarian cancer. |
Page:44—47 |
| 45. Association between bacterial vaginosis and cervical intraepithelial neoplasia. |
Page:39—43 |
| 46. The accuracy of cervical cancer and cervical intraepithelial neoplasia diagnosis with loop electrosurgical excisional procedure under colposcopic vision. |
Page:35—38 |
| 47. Comparison of concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil versus cisplatin plus paclitaxel in patients with locally advanced cervical carcinoma. |
Page:28—34 |
| 48. ERRATUM: Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia. |
Page:200—200 |
| 49. In reply: Different role of secondary cytoreductive surgery by surgeon's experience and hospital facility. |
Page:199—199 |
| 50. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. |
Page:198—198 |
| 51. A single horn endometrial carcinoma of a uterus bicornis unicollis. |
Page:195—197 |
| 52. A case of non-gestational choriocarcinoma arising in the ovary of a postmenopausal woman. |
Page:192—194 |
| 53. A case of neutrophilia related to a cytokine-producing relapsed squamous cell carcinoma of the uterine cervix arising from the rectovaginal septum. |
Page:187—191 |
| 54. Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery. |
Page:181—186 |
| 55. Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary. |
Page:176—180 |
| 56. Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer. |
Page:169—175 |
| 57. Treatment of the patients with abnormal cervical cytology: a "see-and-treat" versus three-step strategy. |
Page:164—168 |
| 58. Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. |
Page:158—163 |
| 59. Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer. |
Page:151—157 |
| 60. Prognostic significance of neutropenia during adjuvant concurrent chemoradiotherapy in early cervical cancer. |
Page:146—150 |
| 61. JSGO's 46th Biannual Meeting, July 10-12, 2009. |
Page:145—145 |
| 62. Recent advances of robotic surgery and single port laparoscopy in gynecologic oncology. |
Page:137—144 |
| 63. International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer?. |
Page:135—136 |
